BeOne Medicines (ONC) EBIT (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.06% |
| Dec 31, 2025 | 13.44% |
| Sep 30, 2025 | 85.60% |
| Jun 30, 2025 | 691.61% |
| Mar 31, 2025 | 113.98% |
| Dec 31, 2024 | 33.96% |
| Sep 30, 2024 | -12.23% |
| Jun 30, 2024 | 59.00% |
| Mar 31, 2024 | 31.90% |
| Dec 31, 2023 | -186.48% |
| Sep 30, 2023 | 57.97% |
| Jun 30, 2023 | 14.15% |
| Mar 31, 2023 | 20.78% |
| Dec 31, 2022 | -6.90% |
| Sep 30, 2022 | 0.24% |
| Jun 30, 2022 | 0.88% |
| Mar 31, 2022 | -332.62% |
| Dec 31, 2021 | 141.22% |
| Sep 30, 2021 | 2.64% |
| Jun 30, 2021 | -776.73% |
| Mar 31, 2021 | 114.47% |
| Dec 31, 2020 | -10.17% |
| Sep 30, 2020 | -22.64% |
| Jun 30, 2020 | 3.98% |
| Mar 31, 2020 | 3.68% |
| Dec 31, 2019 | -24.26% |
| Sep 30, 2019 | -263.81% |
| Jun 30, 2019 | 50.60% |
| Mar 31, 2019 | 38.12% |
| Dec 31, 2018 | -85.84% |
| Sep 30, 2018 | 7.33% |
| Jun 30, 2018 | -47.15% |
| Mar 31, 2018 | -6.75% |
| Dec 31, 2017 | -190.33% |
| Sep 30, 2017 | 298.04% |
| Jun 30, 2017 | -12.57% |
| Mar 31, 2017 | -38.29% |
| Dec 31, 2016 | -7.01% |
| Sep 30, 2016 | -41.42% |
| Jun 30, 2016 | -21.12% |
| Mar 31, 2016 | 22.91% |
| Dec 31, 2015 | -88.51% |
| Sep 30, 2015 | -113.13% |
| Jun 30, 2015 | 33.09% |